These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8908464)

  • 21. Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
    Kiem S; Schentag JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):51-67. PubMed ID: 16508882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.
    Owens RC; Ambrose PG
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):77S-83S. PubMed ID: 17292579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of antibiotic treatment in surgical infections of the abdomen. Undesired effects of antibiotics and future studies.
    Dellinger EP
    Eur J Surg Suppl; 1996; (576):29-31; discussion 31-2. PubMed ID: 8908466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of antibiotics in tissues and tissue fluids: a review.
    Cars O
    Scand J Infect Dis Suppl; 1990; 74():23-33. PubMed ID: 2097711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and the dosage regimen of antimicrobial agents.
    Powers TE; Powers JD
    Ann Rech Vet; 1990; 21 Suppl 1():41S-45S. PubMed ID: 2080846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections.
    Dohmen PM
    J Hosp Infect; 2008 Nov; 70 Suppl 2():15-20. PubMed ID: 19022117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial use in the surgical patient.
    Howe LM; Boothe HW
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1049-60, vi. PubMed ID: 16984826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using pharmacokinetics in drug therapy. VIII: Pharmacokinetic evaluation of antibiotic dosage regimens.
    Henricks JN; Schumacher GE
    Am J Hosp Pharm; 1980 Oct; 37(10):1356-66. PubMed ID: 7424933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro models for prediction of antimicrobial activity: a pharmacokinetic and pharmacodynamic perspective.
    Li RC; Zhu ZY
    J Chemother; 1997 May; 9 Suppl 1():55-63. PubMed ID: 9248963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of antibiotic treatment in surgical infections of the abdomen. Postoperative peritonitis.
    Bohnen JM
    Eur J Surg Suppl; 1996; (576):50-2. PubMed ID: 8908472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations.
    Bergman SJ; Speil C; Short M; Koirala J
    Infect Dis Clin North Am; 2007 Sep; 21(3):821-46, x. PubMed ID: 17826625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
    Pea F; Viale P
    Clin Infect Dis; 2006 Jun; 42(12):1764-71. PubMed ID: 16705585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pharmacokinetics of antibiotics: parenteral and oral administration, distribution in the organism, elimination].
    Segre G; Urso R
    Boll Chim Farm; 1994 Mar; 133(3):127-43. PubMed ID: 8011272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
    Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
    Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and microbiologic evaluation of antibiotic dosage regimens.
    Schumacher GE
    Clin Pharm; 1982; 1(1):66-75. PubMed ID: 7184673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.